Achieve Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Net Income	-29.82	-42.35	-33.15	-14.73	-16.4	Upgrade
Depreciation & Amortization	0.23	0.24	0.25	0.26	0.25	Upgrade
Share-Based Compensation	3.44	3.27	2.19	1.29	1.2	Upgrade
Other Operating Activities	1.67	1.28	1.28	-0.29	-0.28	Upgrade
Operating Cash Flow	-24.48	-37.57	-29.44	-13.47	-15.22	Upgrade
Capital Expenditures	-0.02	0	0	-0.02	-0.05	Upgrade
Change in Investments	0	0	0	0	5.09	Upgrade
Investing Cash Flow	-0.02	0	0	-0.02	5.04	Upgrade
Share Issuance / Repurchase	15.5	19.36	21.68	32.73	16.53	Upgrade
Debt Issued / Paid	0	0	14.93	0	0	Upgrade
Other Financing Activities	-0.22	-0.05	-	-0.05	0.79	Upgrade
Financing Cash Flow	15.28	19.32	36.61	32.68	17.33	Upgrade
Exchange Rate Effect	-0	0	-0	0	0	Upgrade
Net Cash Flow	-9.23	-18.25	7.17	19.19	7.15	Upgrade
Free Cash Flow	-24.5	-37.57	-29.44	-13.49	-15.27	Upgrade
Free Cash Flow Per Share	-1.24	-3.55	-3.63	-4.96	-37.03	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).